Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.850
-0.050 (-2.63%)
At close: Jun 27, 2025, 4:00 PM
1.930
+0.080 (4.32%)
After-hours: Jun 27, 2025, 6:27 PM EDT
Ernexa Therapeutics Revenue
Ernexa Therapeutics had revenue of $535.00K in the twelve months ending March 31, 2025, up 365.22% year-over-year. In the year 2024, Ernexa Therapeutics had annual revenue of $582.00K with 755.88% growth.
Revenue (ttm)
$535.00K
Revenue Growth
+365.22%
P/S Ratio
8.40
Revenue / Employee
$89,167
Employees
6
Market Cap
13.62M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ERNA News
- 2 days ago - Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development - GlobeNewsWire
- 3 days ago - Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement - GlobeNewsWire
- 17 days ago - Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025 - GlobeNewsWire
- 6 weeks ago - Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations - GlobeNewsWire
- 7 weeks ago - Ernexa Therapeutics Announces Participation in the D. Boral Capital Inaugural Global Conference - Newsfile Corp
- 2 months ago - Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025 - GlobeNewsWire
- 2 months ago - Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025 - GlobeNewsWire